Sector: Healthcare / Technology
Platform: Wefunder | Stage: Revenue
Minimum Investment: $200
What They Do
Sofpulse offers a wearable device that uses pulsed electromagnetic field (PEMF) therapy to reduce pain and inflammation.
Why It Might Be the Next Big Thing
The demand for non-opioid pain solutions is growing rapidly. Sofpulse has FDA clearance and early adoption in hospitals.
Snapshot
FDA-cleared device
$13M+ in sales to date
Hospital and surgeon partnerships
Positioned in $30B pain management market
My Take
Healthcare adoption is slow, but non-drug pain management is a structural shift. Sofpulse is well-positioned for that trend.